ACDB Search

Compound Summary

129-56-6

Compound Information

129-56-6

Compound Name:	129-56-6
Compound CID:	8515
Synonyms:	129-56-6 1,9-Pyrazoloanthrone SP600125 Pyrazolanthrone Dibenzocd,gindazol-6(2H)-one More...
Iupac Name:	14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one
InChI:	InChI=1S/C14H8N2O/c17-14-9-5-2-1-4-8(9)13-12-10(14)6-3-7-11(12)15-16-13/h1-7H,(H,15,16)
InChIKey:	ACPOUJIDANTYHO-UHFFFAOYSA-N
Canonical Smiles:	C1=CC=C2C(=C1)C3=NNC4=CC=CC(=C43)C2=O
Isomeric Smiles:	C1=CC=C2C(=C1)C3=NNC4=CC=CC(=C43)C2=O
Molecular Weight:	220.23
Molecular Formula:	C14H8N2O

Compound Structure

2D Structure:

3D Structure:

Computed Properties

129-56-6

Molecular Weight:	220.23
Molecular Formula:	C14H8N2O
Hydrogen Bond Donor Count:	1
Hydrogen Bond Acceptor Count:	2
Rotatable Bond Count:	0
Heavy Atom Count:	17
Complexity:	343

Synonyms

129-56-6

129-56-6	129-56-6
129-56-6	1,9-Pyrazoloanthrone
SP600125	Pyrazolanthrone
Dibenzocd,gindazol-6(2H)-one	Pyrazoleanthrone
SP 600125	Anthra1,9-cdpyrazol-6(2H)-one
SP-600125	Anthra-1,9-pyrazol-6-none
JNK Inhibitor II	2H-Dibenzocd,gindazol-6-one
C.I. 70300	ANTHRA(1,9-cd)PYRAZOL-6(2H)-ONE
NSC 75890	1pmv
UNII-1TW30Y2766	NSC75890
NSC-75890	CHEMBL7064
MLS002693964	2h-dibenzo(cd,g)indazol-6-one
CHEBI:90695	1TW30Y2766
NCGC00015958-03	SAPK Inhibitor II
SMR000015440	SR-01000075840
EINECS 204-955-6	BRN 0746890
2zmd	InSolution™ JNK Inhibitor II
Kinome_3844	Tocris-1496
BiomolKI_000068	Lopac-S-5567
BiomolKI2_000072	cid_8515
DSSTox_CID_20525	DSSTox_RID_79502
CBiol_002049	DSSTox_GSID_40525
Lopac0_000473	BMK1-G8
BSPBio_001066	ChemBiol10705 Compound 4
KBioGR_000406	KBioSS_000406
cc-622	JMC517015 Compound 2
MLS002153267	MLS006011577
SCHEMBL170980	anthra1,9-cdpyrazol-6-one
GTPL5273	CHEMBL1725279
DTXSID2040525	SCHEMBL15583517
4-Aminopyridine-2-carboxylicacid	BCBcMAP01_000053
BDBM16018	dibenzcd,gindazol-6(2h)-one
KBio2_000406	KBio2_002974
KBio2_005542	KBio3_000771
KBio3_000772	Bio1_000335
Bio1_000824	Bio1_001313
Bio2_000373	Bio2_000853
HMS1362F07	HMS1667K13
HMS1792F07	HMS1990F07
HMS2250C03	HMS3229I16
HMS3261O08	HMS3267P06
HMS3295M01	HMS3403F07
HMS3412F05	HMS3654P10
HMS3676F05	HMS3747M19
ALBB-024051	AMY31086
Anthra1,9cdpyrazol-6(2H)-one	BCP05457
EX-A1998	Tox21_110267
Tox21_500473	Anthra1-9-cdpyrazol-6(2H)-one
BDBM50024294	BDBM50433916
CCG-47500	Dibenzocd,gindazol-6(2H)-one #
HSCI1_000136	MFCD00022289
NSC755773	s1460
SBB000595	ZINC96298875
AKOS000115584	Anthra1,9-cdpyrazol-6(2H)-one;
Anthrapyrazolone; 1,9-Pyrazoloanthrone	CCG-100672
CS-0196	DB01782
LP00473	MCULE-7820194475
NSC-755773	SDCCGSBI-0050458.P003
VA10299	1,6-dihydrodibenzocd,gindazol-6-one
2,6-dihydrodibenzocd,gindazol-6-one	IDI1_002128
QTL1_000077	s10332
SMP2_000240	NCGC00015958-01
NCGC00015958-02	NCGC00015958-04
NCGC00015958-05	NCGC00015958-06
NCGC00015958-07	NCGC00015958-08
NCGC00015958-22	NCGC00025186-01
NCGC00025186-02	NCGC00025186-03
NCGC00025186-04	NCGC00025186-05
NCGC00261158-01	WLN: T C6665 1A P IV OMNJ
14,15-diazatetracyclo7.6.1.0^{2,7}.0^{13,16}hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-8-one	14,15-diazatetracyclo7.6.1.02,7.013,16hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one
AC-32051	AS-14374
CAS-129-56-6	HY-12041
JNK Inhibitor II - CAS 129-56-6	K914
SMR002530644	ST018684
DB-041928	EU-0100473
FT-0607068	SW218106-2
EN300-02083	Anthra1,9-cdpyrazol-6(2H)-one & Z-100
K00068	S 5567
SP600125, >=98% (HPLC)	AB00075935-01
SP 600125 & Z-100	129S566
A888840	Anthra1,9-cdpyrazol-6(2H)-one;SP-600125
Q4545713	SR-01000075840-1
SR-01000075840-2	SR-01000075840-4
SR-01000075840-6	SR-01000637108-1
W-108360	BRD-K01567962-001-04-0
BRD-K01567962-001-06-5	BRD-K01567962-001-08-1
BRD-K01567962-001-22-2	Z56785477
F1414-1245	14,15-diazatetracyclo7.6.1.0;{2,7}.0;{13,16}hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one

Experimental Data

129-56-6

Species	Dose	Unit	Control(Avg days)	Treatment(Avg days)	Avg/Med Lifespan Change(%)	Control(Max days)	Treatment(Max days)	Max Lifespan Change(%)	Significant	Strain	Gender	PubMed	Avg/Med Lifespan Change tab
Caenorhabditis elegans	33.000000000000000	umol/L			-22.000000000000000				NS	N2		24134630	Inactive
Drosophila melanogaster	10.000000000000000	mM			23.500000000000000				S	Oregon-R		22363408	Active

Experimental Data Visualization

129-56-6

Statistics Data

129-56-6

Species	Avg/Med Lifespan Change(%)	Max Lifespan Change(%)	Count Reference	Count Data point
Caenorhabditis elegans	-22.000000000000000		1	1
Drosophila melanogaster	23.500000000000000		1	1

Statistics Data Visualization

129-56-6

Compound Name:

129-56-6

Compound CID:

8515

Synonyms:

129-56-6 1,9-Pyrazoloanthrone SP600125 Pyrazolanthrone Dibenzocd,gindazol-6(2H)-one More...

Iupac Name:

14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one

InChI:

InChI=1S/C14H8N2O/c17-14-9-5-2-1-4-8(9)13-12-10(14)6-3-7-11(12)15-16-13/h1-7H,(H,15,16)

InChIKey:

ACPOUJIDANTYHO-UHFFFAOYSA-N

Canonical Smiles:

C1=CC=C2C(=C1)C3=NNC4=CC=CC(=C43)C2=O

Isomeric Smiles:

C1=CC=C2C(=C1)C3=NNC4=CC=CC(=C43)C2=O

Molecular Weight:

220.23

Molecular Formula:

C14H8N2O

Molecular Weight:

220.23

Molecular Formula:

C14H8N2O

Hydrogen Bond Donor Count:

1

Hydrogen Bond Acceptor Count:

2

Rotatable Bond Count:

0

Heavy Atom Count:

17

Complexity:

343

129-56-6

1,9-Pyrazoloanthrone

SP600125

Pyrazolanthrone

Dibenzocd,gindazol-6(2H)-one

Pyrazoleanthrone

SP 600125

Anthra1,9-cdpyrazol-6(2H)-one

SP-600125

Anthra-1,9-pyrazol-6-none

JNK Inhibitor II

2H-Dibenzocd,gindazol-6-one

C.I. 70300

ANTHRA(1,9-cd)PYRAZOL-6(2H)-ONE

NSC 75890

1pmv

UNII-1TW30Y2766

NSC75890

NSC-75890

CHEMBL7064

MLS002693964

2h-dibenzo(cd,g)indazol-6-one

CHEBI:90695

1TW30Y2766

NCGC00015958-03

SAPK Inhibitor II

SMR000015440

SR-01000075840

EINECS 204-955-6

BRN 0746890

2zmd

InSolution™ JNK Inhibitor II

Kinome_3844

Tocris-1496

BiomolKI_000068

Lopac-S-5567

BiomolKI2_000072

cid_8515

DSSTox_CID_20525

DSSTox_RID_79502

CBiol_002049

DSSTox_GSID_40525

Lopac0_000473

BMK1-G8

BSPBio_001066

ChemBiol10705 Compound 4

129-56-6

1,9-Pyrazoloanthrone

SP600125

Pyrazolanthrone

Dibenzocd,gindazol-6(2H)-one

More...